UBS Group’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,781
| Closed | -$11K | – | 7177 |
|
|
2016
Q3 | $11K | Sell |
3,781
-7,015
| -65% | -$20.4K | ﹤0.01% | 5842 |
|
|
2016
Q2 | $16K | Buy |
10,796
+10,021
| +1,293% | +$14.9K | ﹤0.01% | 5605 |
|
|
2016
Q1 | $3K | Sell |
775
-8,056
| -91% | -$31.2K | ﹤0.01% | 6382 |
|
|
2015
Q4 | $89K | Sell |
8,831
-11,147
| -56% | -$112K | ﹤0.01% | 4314 |
|
|
2015
Q3 | $272K | Buy |
19,978
+19,053
| +2,060% | +$259K | ﹤0.01% | 3506 |
|
|
2015
Q2 | $17K | Sell |
925
-1,450
| -61% | -$26.6K | ﹤0.01% | 5644 |
|
|
2015
Q1 | $62K | Sell |
2,375
-5,588
| -70% | -$146K | ﹤0.01% | 4512 |
|
|
2014
Q4 | $167K | Buy |
+7,963
| New | +$167K | ﹤0.01% | 3897 |
|